Edwards Lifesciences CVP JAPAC Lippis Daniel sells 4114 shares at $79.46 on 2025-07-28.

Edwards Lifesciences Corporation (EW) has disclosed that Chief Value Performance (CVP) for the Japan and Asia Pacific region, Daniel J. Lippis, has sold 4,114 shares at a price of $79.46 per share on July 28, 2023.

Edwards Lifesciences Corporation (EW) has disclosed that Chief Value Performance (CVP) for the Japan and Asia Pacific region, Daniel J. Lippis, sold 4,114 shares at a price of $79.46 per share on July 28, 2023. The transaction, reported via SEC Form 4, involved a sale of 4,114 shares at a weighted average price of $79.4605, totaling $326,900 [1]. This sale represents a minor portion of the company's outstanding shares, amounting to less than 0.001% of the approximately 586.6 million shares in circulation [2].

Following the sale, Lippis directly owns 22,001 shares of Edwards Lifesciences. The sale is part of a broader trend of incremental diversification observed in Lippis' trading history. Prior to this transaction, Lippis sold 330 shares on May 9, 2025, for a gross proceeds of $24,560 [2]. The filings indicate that these shares were acquired through equity compensation and are not expected to have a material impact on the company's valuation, float, or liquidity.

Analysts have characterized the filing as routine and not price-moving, noting that the aggregate value and share count are negligible and unlikely to affect the stock's price discovery or liquidity [2]. The filing highlights Lippis' ongoing efforts to diversify his holdings, rather than signaling any strategic shift in the company's operations or financial health.

References:
[1] https://www.tradingview.com/news/tradingview:1e5918624c619:0-edwards-lifesciences-corp-officer-sells-shares/
[2] https://www.stocktitan.net/sec-filings/EW/144-edwards-lifesciences-corp-sec-filing-72c2442c9997.html